Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story - Top-Institutions - MDSpire

Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story

  • By

  • Sana Raoof

  • June 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Francis Crick Institute
    Francis Crick Institute

    London, England

    Key Differentiators

    • Oncology

  • #2

    Harvard University
    Harvard University

    Cambridge, Massachusetts

    Key Differentiators

    • Oncology

  • #3

    Brown School of Public Health
    Brown School of Public Health

    Providence, Rhode Island

    Key Differentiators

    • Public Health
    • Oncology

  • #4

    City of Hope National Medical Center
    City of Hope National Medical Center

    Duarte, California

    Key Differentiators

    • Oncology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Oncology

Original Source(s)

Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story

  • by Sana Raoof

  • June 4, 2026

Related Content

Global trends and emerging frontiers of large language models in cancer research

What RevMed’s pancreatic cancer drug meant for one patient

ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma